Vaccination with structurally modified fungal protein fibrils: a new treatment for synucleinopathies?

Brain. 2024 May 3;147(5):1604-1606. doi: 10.1093/brain/awae115.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Editorial
  • Comment

MeSH terms

  • Animals
  • Fungal Proteins
  • Humans
  • Synucleinopathies*
  • Vaccination

Substances

  • Fungal Proteins